An overall characterization of pediatric acute lymphoblastic leukemia withCRLF2overexpression-Reference-Cited by-同舟云学术

An overall characterization of pediatric acute lymphoblastic leukemia withCRLF2overexpression

Published:2014-06-17 Issue:10 Volume:53 Page:815-823
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Yano Mio¹,Imamura Toshihiko¹,Asai Daisuke¹²,Moriya-Saito Akiko³,Suenobu So-ichi⁴,Hasegawa Daiichiro⁵,Deguchi Takao⁶,Hashii Yoshiko⁷,Kawasaki Hirohide⁸,Hori Hiroki⁶,Kosaka Yoshiyuki⁵,Kato Koji⁹,Horibe Keizo³,Yumura-Yagi Keiko¹⁰,Hara Junichi¹¹,Matsumoto Kenji¹²,Kiyokawa Nobutaka¹³,Oda Megumi¹⁴,Sato Atsushi¹⁵,

Affiliation:

1. Department of Pediatrics; Kyoto Prefectural University of Medicine, Graduate School of Medical Science; Kyoto Japan

2. Division of Pediatrics; Fukuchiyama City Hospital; Fukuchiyama Japan

3. Clinical Research Center, National Hospital Organization Nagoya Medical Center; Nagoya Japan

4. Division of General Pediatrics and Emergency Medicine; Department of Pediatrics; Oita University; Oita Japan

5. Department of Hematology/Oncology; Hyogo Prefectural Children's Hospital; Kobe Japan

6. Department of Pediatrics; Mie University; Tsu Japan

7. Department of Pediatrics; Osaka University; Osaka Japan

8. Department of Pediatrics; Kansai Medical University; Hirakata Japan

9. Department of Pediatrics; Japanese Red Cross Nagoya Daiichi Hospital; Nagoya Japan

10. Department of Pediatrics; Osaka General Medical Center; Osaka Japan

11. Department of Pediatrics; Osaka City General Hospital; Osaka Japan

12. Department of Allergy and Immunology; National Center for Child Health and Development; Tokyo Japan

13. Department of Pediatric Hematology and Oncology Research; National Center for Child Health and Development; Tokyo Japan

14. Department of Pediatrics; Okayama University; Okayama Japan

15. Department of Pediatric Hematology/Oncology; Miyagi Children's Hospital; Sendai Japan

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference23 articles.

1. IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan;Asai;Cancer Med,2013

2. Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol;Cario;Blood,2010

3. Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study;Chen;Blood,2012

4. A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study;Den Boer;Lancet Oncol,2009

5. Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial;Ensor;Blood,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Validation of FusionPlex RNA Sequencing and Its Utility in the Diagnosis and Classification of Hematologic Neoplasms;The Journal of Molecular Diagnostics;2023-12

2. Poor outcome of pediatric B-cell acute lymphoblastic leukemia associated with high level of CRLF2 gene expression in distinct molecular subtypes;Frontiers in Oncology;2023-11-07

3. Clinical, biological, and outcome features of P2RY8‐CRLF2 and CRLF2 over‐expression in pediatric B‐cell precursor acute lymphoblastic leukemia according to the CCLG‐ALL 2008 and 2018 protocol;European Journal of Haematology;2023-03-02

4. The prognostic significance of cytokine receptor-like factor 2 expression and <i>JAK2</i> mutation in pediatric B-cell acute lymphoblastic leukemia: A prospective cohort study;Pediatric Hematology/Oncology and Immunopathology;2023-02-14

5. Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children;International Journal of Molecular Sciences;2022-03-02